You are here

Medicaid

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program

Fierce Pharma

Flag link:

Industry groups in California vie for new Medicaid money

Industry groups in California vie for new Medicaid money

Medical Marketing and Media

Flag link:

Medicaid plans to audit the prices of costliest drugs

Medicaid plans to audit the prices of costliest drugs

ABC News

Flag link:

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

Medicaid, with planned payment pilot, girds for influx of pricey gene therapies

BioPharma Dive

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies

CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies

American Journal of Managed Care

accelerated approval

Flag link:

Centene agrees to $215 million settlement with California for alleged Medicaid overfilling

Centene agrees to $215 million settlement with California for alleged Medicaid overfilling

Medical Marketing and Media

Flag link:

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

With a promising new plan to pay for pricey cures, two states set out to eliminate hepatitis C. But cost hasn’t been the biggest problem

Stat

Washington state

Flag link:

Stanford study: 30% of opioid-naive Medicaid patients develop a dependency after prescription

Stanford study: 30% of opioid-naive Medicaid patients develop a dependency after prescription

MedCity News

Flag link:

Eli Lilly ordered to pay $61M over false rebate calculations

Eli Lilly ordered to pay $61M over false rebate calculations

Beckers Hospital Review

Flag link:

Mallinckrodt Agrees to Pay $260 Million to Settle Lawsuits Alleging Underpayments of Medicaid Drug Rebates and Payment of Illegal Kickbacks

Mallinckrodt Agrees to Pay $260 Million to Settle Lawsuits Alleging Underpayments of Medicaid Drug Rebates and Payment of Illegal Kickbacks

DOJ

False Claims Act

Flag link:

Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial

Eli Lilly's Medicaid rebate payments under fire as whistleblower lawsuit heads to trial

Fierce Pharma

rebate payments

Flag link:

GSK joins a crowd of pharma companies restricting sales under federal program

GSK joins a crowd of pharma companies restricting sales under federal program

Endpoints

Flag link:

Recent Developments in the Medicaid Drug Rebate Program

Recent Developments in the Medicaid Drug Rebate Program

FDA Law Blog

Flag link:

CMS to delay part of controversial Medicaid drug rule

CMS to delay part of controversial Medicaid drug rule

Beckers Hospital Review

Flag link:

The top drugs that could be impacted by an obscure provision in the pandemic relief law

The top drugs that could be impacted by an obscure provision in the pandemic relief law

BioPharma Dive

Flag link:

Report: Covid-19 Vaccine Will Be Covered By Medicaid, Medicare

Report: Covid-19 Vaccine Will Be Covered By Medicaid, Medicare

Forbes

Flag link:

Mallinckrodt could owe a whopping $650M in Acthar Medicaid rebates

Mallinckrodt could owe a whopping $650M in Acthar Medicaid rebates

Fierce Pharma

specialty generics

H.P. Acthar Gel

Flag link:

Feds target Mallinckrodt after joining Medicaid rebate suit worth 'hundreds of millions'

Feds target Mallinckrodt after joining Medicaid rebate suit worth 'hundreds of millions'

Fierce Pharma

H.P. Acthar Gel

whistleblower lawsuit

False Claims Act

Flag link:

Bristol-Myers Squibb reaches tentative deal to end long-running Medicaid rebate lawsuit

Bristol-Myers Squibb reaches tentative deal to end long-running Medicaid rebate lawsuit

Fierce Pharma

Bristol-Myers Squibb

Flag link:

Pfizer, GSK, J&J and more strike $248M deal to exit long-running Medicaid fraud suit

Pfizer, GSK, J&J and more strike $248M deal to exit long-running Medicaid fraud suit

Fierce Pharma

Flag link:

Pages